论文部分内容阅读
多发性硬化(MS)是使年轻患者致残的最常见的疾病。妊娠可对患有MS的妇女病情产生影响,影响复发率,不影响致残率;这种妊娠期MS患者病情变化的机制可能与Th1/Th2细胞失衡有关。MS对妊娠结果不造成不良影响;MS患者妊娠期间的治疗以静脉注射免疫球蛋白最安全,其他治疗方法也可以选用,但要注意这些治疗方法对妊娠产生的影响;性激素替代治疗有望成为新的防止MS患者产后复发的手段。
Multiple sclerosis (MS) is the commonest disorder in young patients. Pregnancy may have an impact on the condition of women with MS, affecting the recurrence rate without affecting the disability rate. The mechanism of the disease in MS patients during pregnancy may be related to the imbalance of Th1 / Th2 cells. MS does not cause adverse pregnancy outcomes; treatment of MS patients with intravenous immunoglobulin during pregnancy is the safest, other treatment options can also be used, but pay attention to these treatments on pregnancy impact; sex hormone replacement therapy is expected to become a new Means to prevent postpartum MS patients with recurrence of the means.